[1] |
SINNAR S A, SCHIFF S J. The problem of microbial dark matter in neonatal sepsis[J]. Emerg Infect Dis, 2020, 26(11):2543-2548.
DOI
PMID
|
[2] |
潘莎. 观察丙种球蛋白静脉滴注在新生儿败血症辅助治疗中的效果[J]. 中国继续医学教育, 2020, 12(27):158-160.
|
[3] |
MOLLOY E J, WYNN J L, BLISS J, et al. Neonatal sepsis:need for consensus definition,collaboration and core outcomes[J]. Pediatr Res, 2020, 88(1):2-4.
DOI
URL
|
[4] |
DONG Y, BASMACI R, TITOMANLIO L, et al. Neonatal sepsis:within and beyond China[J]. Chin Med J (Engl), 2020, 133(18):2219-2228.
|
[5] |
MARKS L, DE WAAL K, FERGUSON J K. Time to positive blood culture in early onset neonatal sepsis:a retrospective clinical study and review of the literature[J]. J Paediatr Child Health, 2020, 56(9):1371-1375.
DOI
URL
|
[6] |
BROMIKER R, ELRON E, KLINGER G. Do neonatal infections require a positive blood culture?[J]. Am J Perinatol, 2020, 37(S2):S18-S21.
DOI
URL
|
[7] |
BOURIKA V, HANTZI E, MICHOS A, et al. Clinical value of serum amyloid-A protein,high-density lipoprotein cholesterol and apolipoprotein-A1 in the diagnosis and follow-up of neonatal sepsis[J]. Pediatr Infect Dis J, 2020, 39(8):749-755.
DOI
URL
|
[8] |
UCIECHOWSKI P, DEMPKE W C M. Interleukin-6:a masterplayer in the cytokine network[J]. Oncology, 2020, 98(3):131-137.
DOI
URL
|
[9] |
GLASER M A, HUGHES L M, JNAH A, et al. Neonatal sepsis:a review of pathophysiology and current management strategies[J]. Adv Neonatal Care, 2021, 21(1):49-60.
DOI
URL
|
[10] |
史源. 新生儿败血症诊断及治疗专家共识(2019版)解读[J]. 中华实用儿科临床杂志, 2020, 35(11):801-804.
|
[11] |
NORDBERG V, IVERSEN A, TIDELL A, et al. A decade of neonatal sepsis caused by gram-negative bacilli-a retrospective matched cohort study[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(9):1803-1813.
DOI
URL
|
[12] |
WATTAL C, KLER N, OBEROI J K, et al. Neonatal sepsis:mortality and morbidity in neonatal sepsis due to multidrug-resistant (MDR) organisms:part 1[J]. Indian J Pediatr, 2020, 87(2):117-121.
DOI
URL
|
[13] |
FLEISCHMANN C, REICHERT F, CASSINI A, et al. Global incidence and mortality of neonatal sepsis:a systematic review and meta-analysis[J]. Arch Dis Child, 2021, 106(8):745-752.
DOI
URL
|
[14] |
KHAN F. C-reactive protein as a screening biomarker in neonatal sepsis[J]. J Coll Physicians Surg Pak, 2019, 29(10):951-953.
DOI
URL
|
[15] |
SAYAR S, KURBUZ K, KAHRAMAN R, et al. A practical marker to determining acute severe ulcerative colitis:CRP/albumin ratio[J]. North Clin Istanb, 2019, 7(1):49-55.
|
[16] |
TSOU P Y, RAFAEL J, MA Y K, et al. Diagnostic accuracy of procalcitonin for bacterial pneumonia in children-a systematic review and meta-analysis[J]. Infect Dis (Lond), 2020, 52(10):683-697.
|
[17] |
GREGORIANO C, HEILMANN E, MOLITOR A, et al. Role of procalcitonin use in the management of sepsis[J]. J Thorac Dis, 2020, 12(Suppl 1):S5-S15.
DOI
URL
|
[18] |
谷磊, 杨玉芹, 王霞. PCT、hs-CRP及二者联合检测对新生儿败血症的诊断价值[J]. 检验医学, 2018, 33(7):597-600.
|
[19] |
BICK A G, PIRRUCCELLO J P, GRIFFIN G K, et al. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis[J]. Circulation, 2020, 141(2):124-131.
DOI
PMID
|
[20] |
RIDKER P M, MACFADYEN J G, GLYNN R J, et al. Comparison of interleukin-6,C-reactive protein,and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice:secondary analyses from the Cardiovascular Inflammation Reduction Trial[J]. Eur Heart J, 2020, 41(31):2952-2961.
DOI
URL
|
[21] |
ISMAIL HASSAN F, DIDARI T, KHAN F, et al. A review on the protective effects of metformin in sepsis-induced organ failure[J]. Cell J, 2020, 21(4):363-370.
DOI
PMID
|
[22] |
WILDE S, OLIVARES K L, NIZET V, et al. Opportunistic invasive infection by group a Streptococcus during anti-interleukin-6 immunotherapy[J]. J Infect Dis, 2021, 223(7):1260-1264.
DOI
URL
|
[23] |
LIU C, FANG C, HE Q, et al. The value of interleukin-6 (IL-6) within 6 hours after birth in the prompt diagnosis of early-onset neonatal sepsis[J]. Transl Pediatr, 2020, 9(5):629-635.
DOI
PMID
|
[24] |
SUN D, WANG Q, ZHANG X, et al. Clinical application of serum inflammatory factors combined with dynamic detection in the diagnosis and treatment of neonatal sepsis[J]. Iran J Public Health, 2021, 50(2):325-332.
DOI
PMID
|
[25] |
WEITKAMP J H. The role of biomarkers in suspected neonatal sepsis[J]. Clin Infect Dis, 2021, 73(2):e391-e393.
|
[26] |
EBENEBE C U, HESSE F, BLOHM M E, et al. Diagnostic accuracy of interleukin-6 for early-onset sepsis in preterm neonates[J]. J Matern Fetal Neonatal Med, 2021, 34(2):253-258.
DOI
URL
|